pharma · Hypoparathyroidism · Postbariatric Hypoglycemia · MBX
MBX Biosciences
MBX Biosciences trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Carmel, USA HQ
2019 Founded
74 Employees
Public company Type
MBX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Carmel, USA
- Founded
- 2019
- Employees
- 74
- Programs
- 7
- Drugs
- 3
- Patents
- 0
MBX Biosciences clinical trials
Registry index of 7 ClinicalTrials.gov studies linked to MBX Biosciences programs — each row shows trial ID, program name, phase, status, and indication.
MBX Biosciences trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for MBX Biosciences.
-
400 µg of MBX 2109 once-weekly by subcutaneous injection — Phase 2
Clinical update -
MBX 1416 (INN imapextide) — Phase 2
Clinical update -
MBX 2109 — Phase 2
Clinical update -
MBX 1416 (Part A) — Phase 1
Clinical update -
MBX 2109 — Phase 1
Clinical update -
MBX 2109 (Part A) — Phase 1
Clinical update -
MBX 4291 — Phase 1
Clinical update